Michael W. Bonney - Aug 2, 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Executive Chair, Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Michael W. Bonney
Stock symbol
ALNY
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/3/2021, 07:31 PM
Previous filing
Jul 19, 2021
Next filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Award $0 +22.5K $0.00 22.5K Aug 2, 2021 Common Stock 22.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F2 The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors.